Our experience with dermofat graft in reconstruction of anophthalmic socket.
Kuzmanović Elabjer B., Busić M., Bosnar D., Elabjer E., Miletić D.
Retrospective Study, published in Orbit (2010) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Retrospective Study
- Journal
- Orbit (2010)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 20812839
- DOI
- 10.3109/01676830.2010.485716
Abstract (original English)
To present our experience with dermofat graft in reconstruction of anophthalmic socket. In period from September 2005 until June 2009, eight patients have undergone orbital surgery of transplantation of dermofat graft. In six patients the dermofat graft was used as the secondary orbital implant after extrusion of hydroxyapatite orbital implant with major defect of bulbar conjunctiva. The other indication for the dermofat graft was correction of deep superior sulcus of the upper lid in anophthalmic socket in two patients. The graft was harvested from the left side of the belly. The size of the graft purposely exceeded the size of the defect to account for the expected tissue resorption. We experienced no major complication. Approximately 20-40% of dermofat graft reduction was noticed in 3-months period postoperatively. It took 6-8 weeks for the graft to fully epithelize from the conjunctival edge. Silicone conformer was introduced for that period of time. Subsequently, in two out of six patients with dermofat graft as the secondary implant, fornix had to be reconstructed later on with oral mucosa graft. Dermofat graft is a valuable material in orbital reconstruction especially in anophthalmic socket.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • Without an adequate control group, treatment effects cannot be separated from other factors.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.